Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

Clinical trial NCT02144051 · COMPLETED

Trial details

NCT number: NCT02144051
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor

Start date: 2014-05-01
Primary completion: 2016-03-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.